Tsutomu Matsubara

4.5k citations
71 papers · 3.6k indexed · h-index 31
Topics
Drug Transport and Resistance Mechanisms (14 papers)Pharmacogenetics and Drug Metabolism (13 papers)Liver Disease Diagnosis and Treatment (12 papers)
Partner nations
JapanUnited StatesChina

In The Last Decade

Tsutomu Matsubara

69 papers receiving 3.6k citations

Peers

Tsutomu Matsubara
Comparison fields: 5 of 119
  • Molecular Biology 1.3k
  • Epidemiology 980
  • Oncology 733
  • Pharmacology 605
  • Physiology 581
Replace Richard A. Weisiger with:
Richard A. Weisiger United States
Anne T. Nies Germany
Jonathan Maher United States
Zhanjun Jia China
Norbert Katz Germany
Robert Safirstein United States
Satoru Kakizaki Japan
P D Berk United States
Rudi Schmid United States
Kenichi Furihata Japan
Tsutomu Matsubara relative to Richard A. Weisiger United States Richard A. Weisiger's profile →
Citations per field
00.5×7.3×
Richard A. Weisiger · 1×
Citations per year

Countries citing papers authored by Tsutomu Matsubara

Since Specialization
Citations

This map shows the geographic impact of Tsutomu Matsubara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsutomu Matsubara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsutomu Matsubara more than expected).

Fields of papers citing papers by Tsutomu Matsubara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsutomu Matsubara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsutomu Matsubara. The network helps show where Tsutomu Matsubara may publish in the future.

Co-authorship network of co-authors of Tsutomu Matsubara

This figure shows the co-authorship network connecting the top 25 collaborators of Tsutomu Matsubara. A scholar is included among the top collaborators of Tsutomu Matsubara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsutomu Matsubara. Tsutomu Matsubara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 5
5 13
6 1
7 9
8 31
9 23
10 9
11 10
12 113
13 76
14 30
15 19
16 31
17 152
18 216
19 50
20 1

About Tsutomu Matsubara

Tsutomu Matsubara is a scholar working on Pharmacology, Hepatology and Biochemistry, having authored 71 papers that have together received 3.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Liver Disease Diagnosis and Treatment (12 papers). The work is most often cited by research in Pharmacology (605 citations), Hepatology (348 citations) and Biochemistry (295 citations). Tsutomu Matsubara has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Frank J. Gonzalez, Yatrik M. Shah, Kristopher W. Krausz, Fei Li, Naoki Tanaka, Aijuan Qu, Andrew D. Patterson, Kiyoshi Nagata, Shinji Ito and Yasushi Yamazoe. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026